Salvage nintedanib plus low-dose ruxolitinib therapy for bronchiolitis obliterans syndrome refractory to calcineurin inhibitors and glucocorticoids after allogeneic transplantation

Bronchiolitis obliterans syndrome (BOS) is a severe pulmonary complication following allogeneic hematopoietic stem cell transplantation (allo-HSCT) with limited therapeutic options once refractory to standard immunosuppression. We conducted a pilot study from January 2018 to December 2024, enrolling...

Description complète

Détails bibliographiques

Auteurs principaux:	Ya Luo, Ying Wu, Qiu-Sha Huang, Xian-Ying Yin, Qian-Nan Shang, Yi-Han Yang, Ao-Ran Zhang, Tong Su, Xiao-Han Su, Su-Xuan Liu, Zheng-Li Xu, Jing Liu, Xiao-Dong Mo, Yu-Qian Sun, Yu Wang, Meng Lv
Format:	Artigo
Langue:	Inglês
Publié:	SAGE Publishing 2026-04-01
Collection:	Cell Transplantation
Accès en ligne:	https://doi.org/10.1177/09636897261438731
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!